This investigation compared the effects of feeding rats diets containing food grade white oil processed by either conventional oleum treatment or the more modem method of catalytic hydrogenation. In two separate experiments, male or female Fischer-344 rats were given free access for 90 days to diets containing 0, 10, 100, 500, 5,000, 10,000, or 20,000 ppm of either oleum-treated white oil (OTWO) or hydrotreated white oil (HTWO). There were no mortalities and no adverse clinical signs associated with feeding either white oil. Treatment-related effects evidenced by hematological, clinical chemical, and pathological changes were generally dose-related and more marked in female than in male rats, and the OTWO caused a greater pathological response than the HTWO. Tissue residues of saturated hydrocarbons were up to 5.2 times higher in female rats than in males. Rats fed 5,000 ppm or more of either white oil showed dose-related alterations in several hematological and clinical chemistry variates associated mainly with hepatic damage or functional alteration. At necropsy, mesenteric lymph nodes were enlarged, and increases in weight of liver, kidney, and spleen were significant. Microscopic changes were characterized by multifocal lipogranulomata in mesenteric lymph node and liver. No changes were observed in rats fed OTWO or HTWO for 90 days at dietary concentrations of 10 or 100 ppm, equivalent to a minimum intake of 0.65 and 6.4 mg/kg/day, respectively. Differences in degree of pathological response associated with each oil may have been due to their differences in specification rather than processing method.
INTRODUCTION
Food-grade mineral hydrocarbons and medicinal white oils (liquid paraffins), petrolatums, and petroleum waxes consist almost entirely of saturated hydrocarbons highly refined to defined standards from paraffinicor naphthenic-type crude petroleum oils (5, 7, 14) . The density, molecular weight range, and relative proportions of the paraffinic and naphthenic hydrocarbon constituents are related to the physical state and viscosity specification of each product as well as to the crude petroleum source from which it was refined (7) . Mineral hydrocarbons are exten-sively used in food processing as binders, lubricants, or coating agents, and regulatory authorities have set maximum permissible concentrations of these substances for different classes of food product (15, 28) . Liquid paraffin is also taken orally for its traditional medicinal use as an aperient (23) , and hydrocarbons of a wide range of structures including saturated forms may potentially originate from a multitude of natural food sources (17, 26) .
No treatment-related effects have been previously reported from chronic feeding studies with rats offered 2-10% of dietary mineral hydrocarbons, incorporated as either white oil (33) , petrolatum (30) , or petroleum wax (34) . In other investigations using rabbits, rats, and guinea pigs (11, 18, 33, 36) , the intestinal absorption of mineral hydrocarbons has been confirmed following oral administration of large volumes. Associated histological lesions in intestinal mucosa, mesenteric lymph node, liver, or spleen were characterized by foci of vacuolated macrophages containing saturated hydrocarbons corresponding by chemical analysis to those administered. In these investigations, no attempts were made to establish a no observable effect level (NOEL).
Lipoid oil droplets within phagocytic cells in small lipogranulomata have also been described in human liver, spleen, and lymph node (4, 27, 32, 36) . Chemical analysis has shown the lipoid material to consist of mixtures of saturated hydrocarbons with a high proportion of polycyclic alkanes typical of exogenous mineral oil. The presence of the lipogranulomata was also correlated with tissue concentrations of saturated hydrocarbons (4, 27) . Epidemiological studies conducted between 1970 and 1971 (8, 9) showed that the incidence of splenic lesions of follicular (mineral oil) lipidosis in humans varied from approximately 50% (Australia, North America, New Zealand) to nil (Africa, Central and South America). Although the oil droplets and lipogranulomata may persist for years in humans (22) , they are concluded to represent incidental changes of no actual functional or clinical significance (8, 9, 12, 22, 41) . Consequential lesions associated with the intestinal absorption of mineral oil in humans have only been observed following abuse by prolonged oral administration (3, 29) .
The refining of mineral hydrocarbons for food and medicinal use may include processing by either conventional oleum treatment (6) or the more modem method of catalytic hydrogenation (24) to remove or saturate, respectively, potentially harmful aromatic compounds. Detailed chemical analysis of comparable white oils and waxes has shown that the final hydrocarbon composition of products produced by either method is similar (7) . However, there are no published toxicological studies in which laboratory species have been concurrently fed white oils processed by either of the two methods, and the question has been raised concerning the comparative effect of catalytically hydrogenated versus conventionally processed white oils. The following investigation was originally conducted to specifically answer this question of comparative effect. In an initial experiment, an oleum-treated white oil (OTWO) or a hydrotreated white oil (HTWO) was fed to male and female rats for 90 days and a full range of clinical, hematological, and pathological parameters was monitored. In a subsequent study, aimed only at establishing a NOEL for each white oil, the parameters monitored were limited to the principal pathological effects in female rats, which showed a greater response to treatment than males.
MATERIALS AND METHODS

Test White Oils
The two test white oils were clear, colorless liquids, both derived from naphthenic crudes of different viscosity specification. The first, the OTWO, was refined by oleum treatment following vacuum distillation of atmospheric residue (so-called conventional refining). This white oil had a specific gravity of 0.874 at 15°C and viscosity of 26 mm2/ sec at 40°C. The second test oil, the HTWO, was produced by hydrotreatment alone of the vacuum distillate of an atmospheric residue. The HTWO had a specific gravity of 0.878 at 15°C and viscosity of 69 mm2/sec at 40°C. Both white oils conformed to all British Pharmacopoeia standards (5) for these substances.
Diet Preparation
The test oils were separately incorporated into powdered laboratory rat diet, LAD2 (Special Diet Services, Witham, Essex), at concentrations ranging from 10 to 20,000 ppm ( Table 1 ). Each oil was first dissolved in solvent (&dquo;DISTOL&dquo;-grade hexane, Fisons) and a premix was used to achieve homogenous dispersal in each batch of final test diet. An equivalent volume of solvent was also mixed with control diet. Achieved concentration and homogeneity of diets were always within 11 % of nominal values. Analysis of dietary residues of hexane within 20 hr of mixing showed concentrations up to 251 ppm, which had usually evaporated to below detectable limits (10 ppm) within 22 days. Batches of diet were initially offered to rats within 7 days of preparation.
Animals and Feeding Regime
Animals were housed under humane conditions in accordance with UK Home Office regulations (40). In two separate feeding studies, the test and control diets were offered ad libitum for 90 days to individually caged Fischer-344 rats (Charles River, Manston, Kent), commencing at 6-8 weeks of age. In the first study, Experiment 1, both oils were fed to male and female rats at dietary concentrations of 0.5, 1.0, or 2% (5,000, 10,000, or 20,000 ppm). In the second study, Experiment 2, female rats received diets containing 10, 100, 500, 5,000, 10,000, or 20,000 ppm of each oil. The calculated range of mean daily intakes (mg/kg/day) of each respective diet between weeks 1 and 13 is shown in Table II. Clinical Assessment, Hematology, and Clinical Chemistry ' Rats were observed daily throughout each experiment. Body weight and food intake were measured weekly. In Experiment 1, cardiac blood was col- a In Experiment 1, numbers in parentheses indicate rats for tissue analyses, and in Experiment 2 rats for necropsy and histopathology after 25 days feeding. lected at terminal necropsy for hematology and clinical chemistry. Tail vein blood was taken 7 days prior for whole blood glucose analysis. Hematological variates monitored (Coulter S-Plus 1; Coulter Medical Electronics, Hialeah, FL) were packed cell volume; total erythrocyte, leucocyte, and platelet count; hemoglobin concentration; mean corpuscular and mean platelet volume; mean corpuscular hemoglobin; mean corpuscular hemoglobin concentration ; and erythrocyte and platelet volume distribution width. Plasma variates analyzed by autoanalyzer (Hitachi 705; Hitachi Ltd., Tokyo) included concentration of glucose, total protein, urea nitrogen, calcium, inorganic phosphate, total cholesterol, triglycerides, total bilirubin, and creatinine as well as activities of alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, y-glutamyl transpeptidase, and lactate dehydrogenase. Separation and quantification of plasma proteins was by electrophoresis (Gelman Sepratek and Densitometer ACD 18; Gelman Instrument Co., Ann Arbor, MI). Plasma levels of sodium and potassium were analyzed by flame photometry (Model 943; Instrumentation Laboratories, Cheshire, UK), whereas plasma chloride concentration was measured by coulometry (Digital Chloridometer; Haake Buchler Instruments, Saddle Brook, NJ).
Necropsy, Histopathology, and Tissue Analysis
At terminal necropsy, rats were euthanized by exsanguination under deep barbiturate anesthesia. In Experiment 1, each rat was subjected to full macroscopic examination. Brain, heart, liver, kidneys, spleen, and testes were weighed. Samples of an extensive range of tissues, including any showing gross changes, were fixed in 10% neutral-buffered formalin, with 1 % acetic acid for eyes. Light microscopy was conducted on paraffin-embedded, hematoxylin and eosin (H&E)-stained sections of these routinely processed tissues from all rats in the control and 20,000 ppm-treated groups. For animals from the 5,000-and 10,000-ppm dose groups in Experiment 1, lung, liver, kidneys, spleen, mesenteric lymph node, and any macroscopic change were also processed for microscopy.
At terminal necropsy in Experiment 1, 5 additional rats of each sex in the control and 20,000 ppm-treated groups were euthanized (Table I) and liver and mesenteric lymph node processed for frozen sections stained with Sudan IV and osmium tetroxide to differentiate saturated and unsaturated TABLE 11 . -Calculated range (weeks 1-13) of mean daily intake of white oils fed to rats at fixed dietary concentrations from 10 to 20,000 ppm.a Abbreviations: HTWO = hydrotreated white oil; OTWO = oleum-treated white oil. &dquo; mean daily intake greatest during weeks 1 and 2. In Experiment 1, only dietary concentrations of 5,000-20,000 ppm were fed. lipids (31 ) . Liver and kidney from these rats were also retained at -18°C for analyses for total hydrocarbon content. The tissues were saponified with potassium hydroxide in isopropanol, rendered aqueous, and extracted with hexane. After concentration, the extract was passed through a column of alkaline alumina and the eluate analyzed by highperformance liquid chromatography with refractive index detection.
In Experiment 2, rats were submitted to necropsy after 25 or 90 days (Table I) . At the terminal necropsy, liver and spleen of all rats were weighed, and liver, spleen, and mesenteric lymph nodes from 5 rats per treated group and 10 control rats were processed routinely for H&E-stained sections and light microscopy. Histological changes in sections of mesenteric lymph node, liver, and spleen from rats in both Experiments 1 and 2 were peer-reviewed by an independent consultancy service.
Statistical analysis of data was accomplished by analysis of variance (35) with a modified Student's t-test procedure (16) for food intake, clinical chemistry, and hematological variates. The Wilcoxon twosample rank sum test (19, 25) was also applied to ensure sensitivity of these analyses. Histological observations were tested for significance using Fisher's exact test (21 ) .
RESULTS
Clinical Findings
There were no deaths nor any adverse clinical signs caused by feeding either OTWO or HTWO at dietary concentrations up to the maximum of 2% (20,000 ppm). The only effect noted was a mild increase in food intake (p <_ 0.05) of males fed 2% OTWO during weeks 3-6 of the study. In Experiment 1, the mean daily intake of each oil by male or female rats fed the same respective dietary concentrations was similar (Table II) . However, because female rats consumed more diet per unit body weight than males, comparative mean daily intake of white oil was approximately 5.4-18.1 °lo higher in females. In Experiment 2, the mean daily intake of each white oil by female rats was slightly greater than at equivalent dietary concentrations in Experiment 1 (Table II) .
Hematology and Clinical Chemistry
The only hematological changes attributed to treatment were slight leukocytosis and granulocytosis in rats of both sexes fed 20,000 ppm (2%) of either white oil, with slight hypochromic microcytic anemia in the 20,000-ppm OTWO-fed females.
Clinical chemistry findings in rats fed 5,000 ppm (0.5%) or more of either white oil (Table III) bance, the effect being dependent on sex as well as on the type and dietary concentration of white oil.
Female rats were more affected than males, and rats fed OTWO had a greater number of significantly altered variates than those receiving HTWO.
Necropsy
At necropsy, treatment-related macroscopic findings or organ weight changes occurred in mesenteric lymph node, spleen, liver, and kidney. Enlarged mesenteric lymph nodes were observed in female rats fed 500-20,000 ppm OTWO or HTWO, the respective incidences ranging up to 70 or 20% at the highest treatment level. In male rats, 20% of those fed 5,000-20,000 ppm OTWO had enlarged mesenteric lymph nodes, but in males offered diets containing up to 20,000 ppm HTWO, mesenteric lymph nodes appeared normal.
Significant, usually dose-related increases in splenic weight were also noted in male and female rats (Table IV) . Splenic weight changes were most marked in the 20,000-ppm OTWO-treated female group in which the mean splenic weight was increased by > 80%. Dose-related increases in liver weight (Table IV) were also recorded in male or female rats fed diets containing 5,000 ppm or more of each white oil. Again, the increases were most marked in the 20,000-ppm OTWO-fed female group in which the mean liver weight was increased by 28%. Although increases in renal weight were <9%, they were nevertheless significant in females fed 10,000 or 20,000 ppm OTWO.
Tissue Analysis
Analysis of liver and mesenteric lymph node for total hydrocarbon residues (Table V) showed higher tissue concentrations in females than in males. Residues were below detectable limits in control tissues.
In both liver and mesenteric lymph node of treated rats, total hydrocarbon concentrations were greater in OTWO-fed rats than in those receiving HTWO, but in each case the actual values in females were approximately 3.7-5.2 times those in males.
Histopathology
There were no treatment-related histological changes in mesenteric lymph node or liver of rats fed 500 or 10,000 ppm of either white oil for 25 days (Experiment 2). After 90 days, lesions were found in mesenteric lymph node, liver, and spleen. Consistent with results of hematology, clinical chemistry, gross necropsy, and tissue residue analyses, histopathological findings were more marked in female rats, and male or female rats fed OTWO were more affected than those receiving HTWO.
In mesenteric lymph node of untreated control rats, there were small macrophage aggregates and syncytia. In mesenteric lymph node of rats fed diets containing either white oil, there were increased numbers of these macrophage accumulations as well TABLE V.-Total hydrocarbon residues (mg/g) in liver and mesenteric lymph node of rats fed white oils at dietary levels of 20,000 ppm for 90 days. as multiple small granulomatous foci in the cortex and medulla (Fig. 1 a) . The granulomata were characterized by foci of macrophages and epitheloid cells containing vacuoles (Fig. 1 b) corresponding to Sudan IV-positive, osmium tetroxide-negative, intracellular lipoid droplets. The frequency and severity of the mesenteric lymph node changes (Table VI) were related to the type of white oil, sex, and dose, being most marked in female rats fed 20,000 ppm OTWO. There were no histopathological changes in mesenteric lymph node of rats fed OTWO or HTWO at dose rates up to and including 10 and 500 ppm, respectively, equivalent to a mean daily intake of 0.65-1.2 or 32.5-57.6 mg/kg/day of each white oil (Table II) .
Histopathological changes in liver occurred in female rats fed either of the two white oils and were more severe in the OTWO-treated rats (Table VI) . In male rats, very slight treatment-related hepatic changes occurred only in the two highest exposure OTWO-fed groups. The hepatic lesions were characterized by formation of occasional to frequent microgranulomata. These focal changes were usually centrilobular ( Fig. 2a ) but showed a diffuse distribution in the most severe cases. The foci were composed of macrophages, lymphocytes, epitheloid cells, fibroblasts, and occasional multinucleate Langhans'-type giant cells (Fig. 2b) . In rats with the more severe lesions, areas of necrosis were present within granulomata, occasionally associated with hepatocellular degeneration and necrosis as well as a nonsuppurative inflammatory response in the surrounding parenchyma. As in mesenteric lymph node, small Sudan IV-positive, osmium tetroxide-negative intracellular lipoid droplets were observed in lesions. The granulomatous changes were accompanied by slight to moderate centrilobular Kupffer cell hypertrophy, vacuolation, and pigmentation (Table VI) . Hepatic changes, based on the occurrence of Kupffer cell hypertrophy, were not observed at dietary concentrations of 10 or 100 ppm for OTWO and HTWO, respectively, equivalent to mean daily intakes of 0.65-1.2 or 6.4-11.5 mg/kg/ day (Table II) . Lipoid droplets and microgranulomata were not observed in the spleen of male or female rats. In males, there was chronic capsular splenitis in groups treated with 5,000 ppm or more of either white oil. In female rats, chronic capsular splenitis occurred in the 20,000-ppm OTWO-treated group. The re-lationship of this change to treatment was not determined. Increased splenic extramedullary hemopoiesis was observed in females treated with 5,000 ppm or more of either white oil. 
DISCUSSION
Previous studies with white oils or model paraffinic or naphthenic hydrocarbons dosed orally in laboratory animals (10, 11, 18, (36) (37) (38) (39) and humans (3, 4, 8, 9, 12, 20, 22, 27, 29, 36, 41) have shown that saturated hydrocarbons may be absorbed unmetabolized from the intestinal tract and pass, via lymphatics, to the vascular system. The degree of absorption may vary depending on the dose rate, method of administration, physical state, and molecular weight of the hydrocarbon (1, 10, 11, 13, (37) (38) (39) . Continuous dietary intake of low levels (1,000 ppm) of individual hydrocarbons such as heptadecane or dodecylcyclohexane may be associated with up to 99% absorption and dose-dependent tissue accumulation of 6-7% of the unmetabolized hydrocarbons, particularly in body fat. Metabolism is by w-oxidation, {3-oxidation, and incorporation of metabolites into normal lipid pathways of synthesis and degradation. In humans, lipoid oil droplets and associated lipogranulomata are recognized in liver, spleen, and lymph node when tissue residues of saturated hydrocarbon reach approximately 0.2 mg/g (4) . An increased proportion of higher molecular weight hydrocarbons in tissue residues compared to mineral oil has been suggested to result from slower metabolic breakdown of the compounds with higher molecular weight (27, 32) . This is the first study in laboratory animals to show effects associated with dietary intake of low concentrations (<2%) of white oil. The comparative effects of the white oil processed by catalytic hydrogenation (HTWO) were qualitatively similar to those associated with the conventionally processed OTWO. There were no clinical signs or mortality due to treatment. The principal pathological changes and associated hematological and clinical chemistry findings were a result of intestinal absorption of each white oil and its passage via mesenteric lymphatics to the vascular system. Subsequent accumulation in mesenteric lymph node and liver led to the formation of typical lipoid oil droplets and the associated foreign body-type granulomatous inflammatory response. The distribution of granulomatous changes observed in the current investigation was similar to a previous study in which rats were fed mineral oil mixed in diet (36) . Similar histopathological changes have also been observed in intestinal mucosa, Peyer's patches, colon, and spleen of rabbits, mice, guinea pigs, and humans following ingestion of mineral oil (18, 20, 27, 36) . No pathological changes were observed in mesenteric lymph node after 25 days feeding up to 20,000 ppm white oil to these rats. This finding is in line with that from a previous rat study using 50,000 ppm mineral oil in which mesenteric nodal lesions were first noted after 6 weeks of dietary exposure (36) .
Although the granulomatous lesions in the liver of these rats were similar in nature to those previously reported following ingestion of white oil by laboratory animals and humans (4, 8, 9, 12, 18, 22, 36, 41) , differences were noted in distribution and severity. In the current study and in one previous investigation in rabbits (18) , a predominantly centrilobular distribution of granulomatous changes was observed, but in other experiments in rat, rabbit, and guinea pig, lesions showed a portal or periportal predisposition (36) . In humans, the reported incidence and distribution of hepatic lipogranulomata associated with ingestion of white oil has varied depending on the pathological technique employed (41 ) . With the use of needle biopsy (12, 22) , lipogranulomata were observed in 5.8% of biopsy samples, with a principally paravenular centrilobular location. Histological examination of conventional liver sections from autopsy revealed an incidence up to 48% (8, 9, 41) , lesions being predominantly portal and periportal in distribution. Approximately 10% of these cases also had paravenular changes.
The results of the present study indicated that female F344 rats may have been more susceptible than the males to the pathological effects of the 2 white oils. Such an effect has not been previously noted in laboratory studies with rats, mice, rabbits, and guinea pigs given mineral oil by oral gavage or incorporated in diet (18, 30, 36) . The increased severity of pathological effects in these female rats when compared to the males was very likely related to their 3.7-5.3 times greater residual levels of unmetabolized hydrocarbons in mesenteric lymph node and liver. The reason for this difference is not clear.
The daily mean intake of each white oil per unit body weight was estimated to be up to 18% higher in female rats, but this difference alone may not have entirely accounted for the disparity between sexes.
To determine whether or not there are further differences in the toxicokinetics of mineral hydrocarbons in male and female rats would require additional studies. Previous kinetic studies in rats with individual model paraffinic and naphthenic hydrocarbons have used only male animals (37) (38) (39) .
The pathological changes in these subchronic rat dietary studies were qualitatively similar to those observed in previous investigations in laboratory animals when large doses of mineral hydrocarbons were administered on a prolonged basis, either by oral gavage or incorporated in diet (18, 36) . However, the findings in this study were associated with much lower intakes of white oil. Based on the histopathological findings in liver and mesenteric lymph node, the respective NOELs for OTWO and HTWO were approximately 0.65 and 6.4 mg/kg/day. The results contrast with those from several other published (30, 33, 34) and unpublished (2) studies in which experimental animals were fed white oil in the diet for 90 or more days without treatmentrelated effects. In the unpublished studies, no treatment-related changes were observed when 4 OTWOs or HTWOs of different viscosity specifications were offered to rats or dogs at respective dietary intakes calculated on a body weight basis to be at least 108 or 710 mg/kg/day. Further investigation is required to determine why the experimental ingestion of white oils by laboratory animals has led to differences in pathological response, both within and between studies. Within the current study, severity of pathological change was in some way dependent on differences between the two white oils, effects being more marked in both male and female rats fed OTWO. Because processing route itself (oleum treatment versus catalytic hydrogenation) has little effect on white oil composition (7), it is unlikely that processing route per se accounted for the difference in response to each white oil. Nevertheless, compositional differences related to differences in specification of the oils may have been important. Each oil had a different viscosity index, OTWO being less viscous (26 mm2/ sec at 40°C) than HTWO (69 mm2/sec at 40°C). Both paraffinic and naphthenic white oils of lower viscosity contain molecules with a lower mean number of carbon atoms and saturated rings per molecule (7) , and evidence suggests that the intestinal absorption of hydrocarbons can vary inversely with carbon number (1) . It is possible that increased absorption of the lower viscosity OTWO may have at least partially accounted for the higher tissue residues and increased pathological response associated with this substance. Differences in pathological response between studies may also be related to differences in the source and specification of the white oils used as well as variations in the dose rate and method of administration, study duration, and strain of experimental rat.
In conclusion, the pathological findings in these F344 rat feeding studies were qualitatively similar to those previously associated with the ingestion of mineral hydrocarbons by a range of species, but the effects occurred at much lower levels of dietary intake than previously reported. No pathological changes were observed after 25 days of feeding, but after 90 days there were very slight to moderate multifocal granulomatous changes in mesenteric lymph node and liver with Sudan IV-positive, osmium tetroxide-negative lipoid droplets as well as associated hematological and clinical chemistry responses. Increased severity of the granulomatous lesions in female rats compared to males was associated with a 5-18% higher dietary intake of white oil and tissue residues up to 5.2 times greater than in males. Although rats fed the conventionally processed white oil were more affected than those receiving the oil processed by catalytic hydrogenation, differences in the specification of each oil rather than processing method were more likely to have accounted for the variation in degree of pathological response. Further studies would be required to determine any differences in the toxicokinetics of mineral hydrocarbons in male versus female F344 rats as well as any differences in response between strains.
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